CRDA Stock Overview
Engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Croda International Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£28.09 |
| 52 Week High | UK£50.34 |
| 52 Week Low | UK£28.02 |
| Beta | 0.83 |
| 1 Month Change | -13.06% |
| 3 Month Change | -14.80% |
| 1 Year Change | -39.86% |
| 3 Year Change | -64.82% |
| 5 Year Change | -36.33% |
| Change since IPO | 1,653.35% |
Recent News & Updates
Is There An Opportunity With Croda International Plc's (LON:CRDA) 24% Undervaluation?
Mar 30
Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Mar 02 Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.Recent updates
Is There An Opportunity With Croda International Plc's (LON:CRDA) 24% Undervaluation?
Mar 30Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Mar 02 Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around
Feb 18Croda International (LON:CRDA) Has A Somewhat Strained Balance Sheet
Dec 10Earnings Tell The Story For Croda International Plc (LON:CRDA)
Oct 29Returns On Capital Signal Tricky Times Ahead For Croda International (LON:CRDA)
Oct 14Croda International (LON:CRDA) Has A Pretty Healthy Balance Sheet
Sep 11Croda International Plc's (LON:CRDA) Intrinsic Value Is Potentially 24% Below Its Share Price
Aug 12Croda International Plc's (LON:CRDA) Share Price Matching Investor Opinion
Jul 30Croda International (LON:CRDA) Could Be Struggling To Allocate Capital
Jun 07These 4 Measures Indicate That Croda International (LON:CRDA) Is Using Debt Reasonably Well
Apr 14Shareholder Returns
| CRDA | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -2.9% | -5.8% | -2.3% |
| 1Y | -39.9% | -35.8% | 3.2% |
Return vs Industry: CRDA underperformed the UK Chemicals industry which returned -32.9% over the past year.
Return vs Market: CRDA underperformed the UK Market which returned 5.4% over the past year.
Price Volatility
| CRDA volatility | |
|---|---|
| CRDA Average Weekly Movement | 4.0% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in GB Market | 9.9% |
| 10% least volatile stocks in GB Market | 2.9% |
Stable Share Price: CRDA has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: CRDA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1925 | 6,027 | Steve Foots | www.croda.com |
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations.
Croda International Plc Fundamentals Summary
| CRDA fundamental statistics | |
|---|---|
| Market cap | UK£3.92b |
| Earnings (TTM) | UK£158.50m |
| Revenue (TTM) | UK£1.63b |
24.7x
P/E Ratio2.4x
P/S RatioIs CRDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRDA income statement (TTM) | |
|---|---|
| Revenue | UK£1.63b |
| Cost of Revenue | UK£894.20m |
| Gross Profit | UK£733.90m |
| Other Expenses | UK£575.40m |
| Earnings | UK£158.50m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Jul 29, 2025
| Earnings per share (EPS) | 1.14 |
| Gross Margin | 45.08% |
| Net Profit Margin | 9.74% |
| Debt/Equity Ratio | 26.8% |
How did CRDA perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield97%
Payout RatioDoes CRDA pay a reliable dividends?
See CRDA dividend history and benchmarks| Croda International dividend dates | |
|---|---|
| Ex Dividend Date | Apr 10 2025 |
| Dividend Pay Date | May 28 2025 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 54 days |
Does CRDA pay a reliable dividends?
See CRDA dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/03 08:29 |
| End of Day Share Price | 2025/04/03 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Croda International Plc is covered by 37 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Bate | Barclays |
| Amy Lian | Barclays |
| James Stewart | Barclays |